A recent analysis published in the American Journal of Transplantation estimates that for the average US patient who has undergone kidney transplantation, failure of the transplanted organ (graft failure) will impose additional medical costs of $78,079 and a loss of 1.66 quality-adjusted life years.
A recent analysis published in the American Journal of Transplantation estimates that for the average US patient who has undergone kidney transplantation, failure of the transplanted organ (graft failure) will impose additional medical costs of $78,079 and a loss of 1.66 quality-adjusted life years. (One quality-adjusted life year is equal to one year of life in perfect health.)
The authors note that given 17,644 kidney transplants in 2017, the total incremental lifetime medical costs associated with graft failure is $1.38 billion and the total quality-adjusted life years lost is 29,289.
The results indicate that efforts to reduce the incidence of kidney transplant failure or to mitigate its impact are urgently needed. “While short-term outcomes for kidney transplant recipients have improved, long-term outcomes have not: ten-year graft failure rates remain higher than 50%,” said corresponding author Rebecca Kee, of Precision Health Economics. “This calls for long-term investment in novel technologies to improve graft survival, given that graft failure is associated with substantial costs and impacts on quality and length of life.”
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/ajt.15750
About Journal
With its high quality content, an average time to decision of 19 days, and an Impact Factor of 7.163 (ranked no. 2 in Transplantation, no. 5 in Surgery), the American Journal of Transplantation is the journal you can’t be without.
The American Journal of Transplantation serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science in this dynamic field. Published monthly, the American Journal of Transplantation provides an essential resource for researchers and clinicians around the world.
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com